1. Introduction {#sec1}
===============

HDAC inhibitors have gained the interest of researchers possibly due to their potency and diverse pharmacological applications. Various structurally diverse HDAC inhibitors possess anti-tumor, anti-histaminic, anti-inflammatory and immune modulatory properties. HDACIs have been known to inhibit induction and proliferation, induce differentiation, and influence a variety of processes such as cell cycle arrest, angiogenesis, and apoptosis of tumor cells in culture and in animal models \[[@bib1], [@bib2]\].

The Zn^2+^ dependent HDACIs have been widely studied as anticancer drugs to suppress the general action of catalyzing deacetylase activity of HDACs in presence of Zn^2+^ as essential cofactor. Among the four classes of HDACs classes I, II, and IV are inhibited by Zn^2+^ binding HDACIs. However, class III HDACs is structurally homologous with the yeast Sir2 protein and requires NAD^+^ as a cofactor instead of Zn^2+^ \[[@bib3], [@bib4]\]. In class I, HDACs 1, 2, 3 and 8 are mostly preferred for binding studies as they are localized in the nucleus, most abundant and ubiquitously-expressed \[[@bib5]\]. The wide active pocket and a larger surface area of HDAC8 is an interesting feature which distinguishes it from other HDAC enzymes \[[@bib6]\]. HDAC8 is ubiquitously expressed in all human tissues and organs as reported in experiments performed on total tissue extracts \[[@bib7], [@bib8], [@bib9]\]. Thus HDAC8 is the most acceptable receptor for such HDAC inhibition. HDAC3 has a unique recruitment to SMRT complex where it interacts with conserved DAD \[[@bib10], [@bib11], [@bib12], [@bib13], [@bib14], [@bib15]\]. The Ser424 residue in the active site of HDAC3 is primarily phosphorylated. Thus dephosphorylation of Ser424 on HDAC3 inhibits HDAC3 activity possibly due to a conformational change that renders it less active. The three FDA approved HDACIs, vorinostat, belinostat and romidepsin have shown considerable anti-cancer activity \[[@bib16], [@bib17], [@bib18]\].

The dietary compounds such as sulforane, genistein, tea polyphenol-catechins, curcumin, diallyl disulphide and revestrol play an important role in regulating key molecular targets like HDAC, DNA methyltransferases etc for the treatment of various diseases \[[@bib19], [@bib20]\]. Diallyldisulphide (DADS) a dietary organosulphur compound exhibits excellent HDAC inhibitory activity, anti-microbial, anti-inflammatory, anticancer, anti-oxidant and antihistaminic activity \[[@bib21], [@bib22], [@bib23], [@bib24]\].

DADS has been reported to metabolize to allylmercaptan (AM) within 30 min of administration. The inhibitory HDAC action of AM was reported better compared to its precursors Diallyldisulfide (DADS) and S-allylmercaptocysteine (SAMC) under cell-free conditions \[[@bib25], [@bib26], [@bib27]\]. Compounds containing thiol moiety such as allyl alcohol and mercaptoethanol have been found to abolish and decrease HDAC inhibitory activity respectively in contrast to compounds containing sulfhydryl group. Therefore the sulfhydryl group of AM plays a major role in HDAC inhibition. Various compounds prepared using synthetic strategies with -(CH)~2~-SH group have been reported with strong HDAC inhibitory action majorly due to -S-Zn binding within the active site \[[@bib28], [@bib29]\].

Owing to the fact that diallyl disulphide metabolizes to AM within few minutes of administration, in the present study the allyl mercaptan moiety of the pre-synthesized DADS derivatives by *Rai et al.* \[[@bib30]\] have been screened for their pharmacokinetics, drug likeliness and potential HDAC inhibitory action *via* *in silico* DFT, ADME and molecular docking studies.

2. Methodology {#sec2}
==============

A preliminary dataset of 7 aryl AM derivatives ([Table1](#tbl1){ref-type="table"}) was selected with electron withdrawing substituents. The derivatives were screened for their drug likeliness and non-toxicity *via* *in silico* studies. The most reactive positions in these compounds were screened using DFT (Frontier orbital and NBO) calculations. The compounds were further screened for their potential HDAC inhibitory activity *via* Molecular docking study.Table 1Aryl allyl mercaptan derivatives with electron withdrawing substituents.Table 1![](fx1.gif)Compound no.XX′1aHNO~2~1bClH1cClCl1dBrH1eBrBr1fHF1gHCF~3~

2.1. Calculation of druglikeliness properties {#sec2.1}
---------------------------------------------

The molecular properties of compounds **1a-g** were calculated using the Molinspiration cheminformatics software ([www.molinspiration.com](http://www.molinspiration.com){#intref0010}). The major druglikeliness parameters calculated include number of atoms, molecular weight, partition coefficient (LogP), hydrogen bond acceptors and donors, topological surface area (TPSA), and Lipinski\'s rule violations \[[@bib31]\].

2.2. Pharmacokinetic and toxicity parameters {#sec2.2}
--------------------------------------------

PreADMET online server 2.0 version \[[@bib32]\]was used to calculate adsorption, distribution, metabolism and excretion (ADME) parameters. The properties calculated were plasma protein binding (PPB), human intestinal absorption (HIA), logKp (degree of skin permeation), Caco2 cell lines and MDCK cell lines barrier penetration. These predicted the oral absorption of the compounds \[[@bib33]\].

2.3. Geometry optimization using density functional theory (DFT) {#sec2.3}
----------------------------------------------------------------

DFT study illustrates the electronic structural properties of the molecules. The DFT calculations were done using Gauss View 5.0 \[[@bib34]\] molecular visualization program and Gaussian 09 program \[[@bib35]\]. The molecular structures of the aryl AM compounds in the ground state were optimized at B3LYP/6-311G++(d,p) level of computation \[[@bib36]\].

The optimized ground state geometry of the most stable conformer was used to predict different structural parameters like bond lengths, bond angles, and dihedral angles.

2.4. Frontier molecular orbital calculations {#sec2.4}
--------------------------------------------

The electronic properties like frontier molecular orbital, HOMO (highest occupied molecular orbital) and LUMO (lowest unoccupied molecular orbital) energies are important for defining reactivity of a chemical species \[[@bib37]\]. The global reactivity descriptors, chemical potential (μ) and hardness (ƞ) described by Parr and Pearson were calculated using equations \[[@bib38]\]:$$\mu = - \frac{I + A}{2}$$$$\text{n} = {(I - A)}/2\ \text{respectively}$$where I is the ionization potential (-E~HOMO~) and A is the electron affinity (-E~LUMO~) as correlated using the Koopman\'s theorem \[[@bib39], [@bib40]\].

2.5. Natural bond order analysis (NBO) {#sec2.5}
--------------------------------------

Reed and Weinhold performed the natural bond orbital (NBO) calculations \[[@bib41]\] which depict the second order interactions between the filled Lewis orbital to empty non-Lewis orbital of a sub-system. These interactions determine the intermolecular delocalization or hyperconjugation within a system. Considering the title compound the second order perturbation theory analysis for Fock matrix in NBO was carried out to evaluate donor acceptor interactions. They result in a loss of occupancy from localized NBO of Lewis structure to empty non-Lewis orbital \[[@bib33]\]. The stabilization energy E(2), for each donor (i) and acceptor (j) is given by the formula:where q~i~ is the donor orbital occupancy, ε~i~ and ε~j~ are diagonal elements and F(i,j) is the off diagonal NBO Fock matrix element. These calculations allow us to analyse the probable charge-transfers and the intermolecular bond paths.

2.6. Molecular docking {#sec2.6}
----------------------

The three dimensional target receptor HDAC8 (PDB ID: 1T67) and HDAC3 (PDB ID: 4A69) structures were retrieved from the Protein Data Bank ([www.rcsb.org](http://www.rcsb.org){#intref0015}). The Schrodinger suite was used to refine protein structure via protein preparation wizard. Prime (Prime v2.0,2012) was used to add missing side chains and hydrogens to the raw protein structure. The crystallized water molecules in the active site present beyond 5 Å were removed using an all atom force field. In order to remove potential steric clashes minimizations on the protein structure were done until the RMSD value (root mean square deviation) reached 0.3 Å for non-hydrogen atoms using OPLS_2005 force field.

The lead targets were prepared using Ligprep function of the Schrödinger suite in which the energy minimization was performed using OPLS_2005 force field. A grid was generated around the receptor using Grid generation program and Glide Docking program respectively. The XP (Xtra Precision) mode of docking was selected in the present case \[[@bib42], [@bib43]\].

3. Results and discussion {#sec3}
=========================

3.1. Druglikeliness properties {#sec3.1}
------------------------------

The compounds **1a-g** obeyed the Lipinski\'s rule of five (i.e MW \< 500, Log P \< 5, number of H bond donors up to 5 and H bond acceptors up to 10) \[[@bib31]\]([Table 2](#tbl2){ref-type="table"}). Thus these designed derivatives depicted drug like properties.Table 2Designed aryl allyl mercaptan compounds with electron withdrawing substituents.Table 2PropertyCompounds1a1b1c1d1e1f1gAMLog P2.943.444.093.574.353.153.591.28TPSA45.8238.8038.8038.8038.8038.8038.8038.80Natoms131112111211144MW195.24184.69219.13215.11308.03168.23218.2474.15nOH30000000nOHNH00000000Nviolations00000000Nrotb32222231Volume169.26159.46172.99163.81181.69150.85174.3874.83

3.2. ADME parameters {#sec3.2}
--------------------

The ADME parameters for the compounds **1a-g** have been given in [Table 3](#tbl3){ref-type="table"}. The human intestinal (HIA) values indicate good oral absorption as the values were above 90%. The negative Kp values indicate poor skin permeation which results in good oral absorption. The PPB values except **1e** were less than 90%. The Caco 2 values were within range of 4--70, indicative of moderate permeability. MDCK values were greater than 25 except for compounds **1c-1e**, indicative of good absorption. Apart from these factors various other parameters need to be considered. The BBB values are less than two which indicates non-neurotoxicity of these compounds. Thus these screened compounds depicted good pharmacokinetics and bioavailability.Table 3Designed aryl allyl mercaptan compounds with electron withdrawing substituents.Table 3PropertyCompounds1a1b1c1d1e1f1gAMBBB1.961.361.021.300.981.651.191.19Caco218.5658.1458.4857.7558.5155.5154.2454.78HIA84.1898.1198.0598.0398.2798.4698.3696.86MDCK35.7542.1311.280.140.18132.1536.60137.61PPB83.6673.2890.8578.1891.6975.7487.6550.56SP-2.21-1.02-0.99-0.93-0.80-1.20-0.77-1.93[^1]

3.3. Geometry optimization {#sec3.3}
--------------------------

The ground state optimized geometry of aryl AM **1a** with NH~2~ substituentis is given in [Figure 1](#fig1){ref-type="fig"}. The structural parameters like bond lengths, bond angles and dihedral angles for the title molecule are given in [Table 4](#tbl4){ref-type="table"}.Figure 1Ground state optimized structure of aryl AM **1a** at B3LYP/6-311G++(d,p) level.Figure 1Table 4Theoretical optimized geometrical properties of aryl AM **1a** at B3LYP/6-311G++(d,p) level.Table 4Bond length (Å)Theoretical calculatedBond angle (˚)Theoretical calculatedBond dihedral (˚)Theoretical calculatedC1-C21.387C2-C31.399C1-C2-C3120.44C3-C41.398C2-C3-C4119.19C1-C2-C3-C4-0.05C4-C51.386C3-C4-C5120.71C2-C3-C4-C50.04C5-C61.400C4-C5-C6119.86C3-C4-C5-C60.03H7-C11.099H7-C1-C2119.31H7-C1-C2-C3179.96H8-C21.096H8-C2-C1119.61H8-C2-C1-C6-179.93H9-C41.102H9-C4-C3118.65H9-C4-C3-C2-179.82H10-C51.099H10-C5-C4119.38H10-C5-C4-C3-179.94C11-C31.459C11-C3-C2119.61C11-C3-C2-C1179.98C12-C111.339C12-C11-C3122.41C12-C11-C3-C2-179.07H13-C111.098H13-C11-C3116.34H13-C11-C3-C20.95H14-C121.104H14-C12-C11120.08H14-C12-C11-C3-0.58C15-C121.479C15-C12-C11122.99C15-C12-C11-C3179.14H16-C151.105H16-C15-C12111.93H16-C15-C12-C115.79H17-C151.106H17-C15-C12108.90H17-C15-C12-C11-111.29S18-C151.827S18-C15-C12108.06S18-C15-C12-C11128.09S18-H191.307H19-S18-C1599.02H19-S18-C15-C12174.53N20-C61.495N20-C6-C5120.15N20-C6-C5-C4179.92O21-N201.215O21-N20-C6119.48O21-N20-C6-C5-0.78O22-N201.215O22-N20-C6119.48O22-N20-C6-C5179.29

The C-C bond lengths of the phenyl ring and allyl moiety are shorter than other C-C bonds verifying the double bond character of the ring and allyl C-C bonds. The average C-C bond length is 1.39 Å which is almost identical to that of diamond, and the C-H distances lie in the range 1.096--1.106 Å. The S-H bond length in aryl AM **1a** is calculated to be 1.307 Å. The preferred bond angle value between successive carbon chain bonds in phenyl ring system is around 119°. Also, the dihedral angles should be nearly 0° or 180° conferring the planarity of the compound. The major dihedral angles which depict the orientation of AM with respect to the phenyl ring *via* S atom, S18-C15-C12-C11, H16 -C15 -C12-C11, H19-S18-C15-C12 with the corresponding values 128.09°, 5.79°, 174.53° respectively, revealed the deviation of planarity by sulphur atom that leads to different conformations of the compound. The different conformations particularly arise due to the non-planarity of sulphur atom as the mercaptan bond can undergo free rotation.

The conformational behavior of the molecule provides useful information regarding drug actions. A detailed conformational theoretical analysis has been carried out in order to understand the conformational properties of the molecules. The presence of double bond on the AM results in the generation of cis and trans isomers. The trans isomer was predicted to be more stable than the cis form as predicted by the B3LYP/6-311G++(d,p) calculations. The internal rotation about the SH bond results in the conformational possibilities. The geometries of the threepossible configurations with their relative stabilities as determined from the excess Gibbs free energies calculated at same level of computation for aryl AM **1a** are displayed in [Figure 2](#fig2){ref-type="fig"}.Figure 2Optimized ground state geometries of conformers of aryl AM **1a** at B3LYP/6-311G++(d,p) level with their relative Gibbs free energies.Figure 2

The relative stability of sub-conformations is not affected by different orientations of phenyl rings in the main configuration (maximum: 0.25 kcal/mol) \[[@bib44]\]. Thus the order of decreasing stability of conformers in compound **1a** is i (0.0 kcal/mol) \>ii (0.0025 kcal/mol) \>iii (11.5137 kcal/mol).

The first conformation is the most stable form as the mercaptansulphur is eclipsed with hydrogens and methyl. For propionaldehyde the carbonyl oxygen is eclipsed with hydrogens and methyl and it has been shown by ^1^HNMR spectra that such types are the preferred conformers in order to minimize the steric effect \[[@bib45]\]. The conformational free energy of compound **1a** is approximately 11.5 kcal/mol in favor of the conformer **i** in which the mercaptansulphur is nearly eclipsed with methyl group. Similarly, for the compounds **1d**, **1e**, **1f**, and **1g** the lowest energy conformer as determined from the lowest Gibbs free energy values ([Table 5](#tbl5){ref-type="table"}) was found to be the one in which sulphur atom was eclipsing with methyl group ([Figure 3](#fig3){ref-type="fig"}). However, for the compounds **1b** and **1c** the lowest energy conformation had mercaptanhydrogen eclipsed with methyl group and such conformations are not present in detectable amount \[[@bib46]\]. Thus the conformational results indicated that the lowest energy conformations for the compounds **1a, 1d, 1e, 1f and 1g** were more stable than for the compounds **1b** and **1c**. These lowest energy conformers have been used for the rest of the studies.Table 5Representative Relative Gibbs free energies of **1(b-g)** conformers indicating the most stable conformation.Table 5CONFORMERSRELATIVE GIBBS FREE ENERGIES (HARTREES)1b1c1d1e1f1g100000020.000218.71452.76030.00010.00010.000530.000318.71542.76140.00020.00020.000940.003418.71552.76150.00100.00020.002750.003518.718036.93120.00110.00090.343060.004818.718136.93740.00140.00264.0966Figure 3Optimized ground state geometries of most stable conformers of i)**1b**, ii) **1c**, iii) **1d**, iv) **1e**, v) **1f** and vi) **1g** at B3LYP/6-311G++(d,p) level with their relative gibbs free energies (kcal/mol).Figure 3

3.4. Frontier molecular orbitals {#sec3.4}
--------------------------------

The calculated electronic properties are listed in [Table 6](#tbl6){ref-type="table"}. The compound **1a** has the lowest frontier orbital gap pertaining to its higher chemical reactivity ([Figure 4](#fig4){ref-type="fig"}). The negative chemical potential values for compounds **1(a-g)** indicate non-spontaneous decomposition which is a prerequisite of this study. The global hardness (ƞ) depicts the resistance towards electron cloud deformation under perturbation observed in a chemical process \[[@bib47], [@bib49]\].Table 6The electronic properties of compounds calculated at DFT-B3LYP/6-311G++(d,p) level.Table 6CompoundE~HOMO~(KJ/mol)E~LUMO~(KJ/mol)E~L~--E~H~ (KJ/mol)η(KJ/mol)μ(KJ/mol)1a-0.12830.01670.1450.0725-0.11161b-0.24520.20710.4520.4523-0.03811c-0.25150.19010.4410.4416-0.06141d-0.12110.04870.1690.1698-0.07241e-0.12780.05130.1710.1734-0.08031f-0.11650.05990.1760.1764-0.05661g-0.12160.04860.1700.1702-0.0730AM-0.26420.02760.2360.1459-0.1183Figure 4Frontier orbital diagram of **1a** using DFT-B3LYP/6-311G++(d,p) method with frontier orbital gap value of 0.145 kcal/mol.Figure 4

Similarly, on the basis of frontier orbital gap, chemical potential and global hardness the compounds **1d, 1e, 1f** and **1g** had lesser frontier orbital gap and negative chemical potential compared to compounds **1b** and **1c** implying that compounds **1b** and **1c** are less reactive as compared to other compounds. For the compounds **1d, 1e, 1f** and **1g** the HOMO of sigma nature is localized over the sulphur atom while in LUMO the electron density is delocalized over the phenyl ring implying electron density transfer from the sulphur atom to the phenyl ring ([Figure 5](#fig5){ref-type="fig"}). This study provides an insight into the binding interactions which could occur majorly *via* the sulphur atom.Figure 5Frontier orbital diagram **a)1b** with frontier orbital gap of 0.452, **b) 1c** with frontier orbital gap value of 0.441, **c) 1d** with frontier orbital gap of 0.169, **d)1e** with frontier orbital gap of 0.171, **e) 1f** with frontier orbital gap of 0.176, **f) 1g** with frontier orbital gap of 0.170.Figure 5

3.5. NBO analysis {#sec3.5}
-----------------

The second order perturbation stabilization energy values E(2) (given in [Table7](#tbl7){ref-type="table"}) revealed significant interactions between Lewis and non-Lewis NBO orbitals for the compound **1a**. The transfer of electron density from oxygen atom lone pair (O22) in antibonding orbitals p(N20-O22) resulted in strong interaction with high stabilization energy 197.72 kcal/mol. Other important interactions include overlap of bonding p(C3-C4) with antibonding orbitals p(C11-C12), p(C5-C6) and p(C1 -C2) with corresponding stabilization energies 38.85, 25 and 20.51 kcal/mol respectively, bonding p(C5-C6) with antibonding orbitals p(C1-C2) and p(C3-C4) with corresponding stabilization energies 21.67 and 20.41 kcal/mol respectively, and bonding p(C1-C2) with antibonding orbitals p(C3-C4) and p(C5-C6) with stabilization energies 20.32 and 21.63 respectively. These interactions result in pronounced decrease in C3/C4, C5/C6 and C1/C2 orbital\'s occupancy (0.36548, 1.6525 and 1.67642 respectively). It also indicates a possibility of hyperconjugation within the phenyl ring and between the ring and allyl carbons. The lone pair interactions include overlap of lone pair (LP2) of oxygen atom (O21) to antibonding orbitals p⁄(N20-O22) with stabilization energy 15.94 kcal/mol. Similarly, the interaction of lone pair (LP2) of oxygen atom (O21) with p(C6-N20) has stabilization energy of 14.39 kcal/mol.Table 7Second order perturbation analysis of the interaction between donor and acceptor orbitals of compound **1a** calculated B3LYP/6--311++G(d,p).Table 7Donor (i)TypeED/eAcceptor(j)TypeED/eE(2)[a](#tbl7fna){ref-type="table-fn"}E(j)-E(i)[b](#tbl7fnb){ref-type="table-fn"}F(i,j)[c](#tbl7fnc){ref-type="table-fn"}C1-C2σ1.983C6-N20σ∗0.1532.790.840.045C1-C2σ1.676C3-C4π ∗0.36520.320.280.068C1-C2σ1.676C5-C6π∗0.37821.630.270.070C1-C6σ1.982C6-N20σ∗0.1532.650.850.044C1-H7σ1.983C2-C3σ∗0.0172.111.030.042C1-H7σ1.983C5-C6σ∗0.0192.021.040.041C2-H8σ1.985C1-C6σ∗0.0192.181.040.043C3-C4σ1.608C1-C2π∗0.31420.510.270.068C3-C4σ1.608C5-C6π ∗0.37825.000.260.073C3-C4σ1.608C11-C12π ∗0.08310.870.300.056C3-C11σ1.977C12-C15σ∗0.0182.360.960.042C4-C5σ1.982C6-N20σ∗0.1532. 760.840.044C4-H9σ1.984C5-C6σ∗0.0192.221.040.043C5-C6σ1.982C6-N20σ∗0.1532.660.850.044C5-C6σ1.652C1-C2π∗0.31521.670.290.071C5-C6σ1.652C3-C4π∗0.36520.410.290.069C5-C6σ1.652N20-O22σ∗0.68013.500.170.046C5-H10σ1.983C1-C6σ∗0.0192.021.040.041C5-H10σ1.983C3-C4σ∗0.0182.131.030.042C6-N20σ1.964N20-O21σ∗0.0695.890.970.068C6-N20σ1.964N20-O22σ∗0.0695.890.970.068C11-C12σ1.919C3-C4π ∗0.01811.680.300.057C11-C12σ1.919C15 -S18σ∗0.0152.880.490.034C11-H13σ1.983C12-H14σ∗0.0173.210.930.049C12-H14σ1.984C11-H13σ∗0.0152.960.940.047C12-C15σ1.983S 18RY∗(1)0.0030.681.120.025C12-C15σ1.983C3-C11σ∗0.0252.860.970.047C15-H16σ1.992S 18RY∗(2)0.0020.531.080.021C15-H17σ1.983C11-C12σ∗0.0842.660.570.035C15-S18σ1.973C11-C12σ∗0.0844.550.530.044S18-H19σ1.992C12-C15σ∗0.0181.410.850.031N20 -O21σ1.979C6-N20σ∗0.1533.600.970.054N20 -O21σ1.979N20-O22σ∗0.0696.121.070.073N20 -O22σ1.979C6-N20σ∗0.1533.600.970.054N20-O22σ1.979N20-O21σ∗0.0696.121.070.073N20-O22σ1.983O 21LP (3)1.35613.430.190.078N20-O22σ1.983C5-C6σ∗0.3795.150.380.044N20-O22σ1.983N20-O22σ∗0.68010.460.270.058S 18CR (3)2.000S 18RY∗(3)0.0000.526.300.051S 18LP (2)1.981C15-H16σ∗0.0173.580.560.040S 18LP (2)1.981C15-H17σ∗0.0142.160.560.031O 21LP (2)1.901C6 -N20σ∗0.15314.390.390.068O 21LP (2)1.901N20-O22σ∗0.06915.940.490.080O 21LP (3)1.356N20-O22σ∗0.680197.720.080.114O 22LP (2)1.901C6-N20σ∗0.15314.400.390.068O 22LP (2)1.901N20-O21σ∗0.06915.940.490.080C3-C4π∗0.365C11-C12π ∗0.08438.850.030.064C 6-N 20π∗0.153N20-O21π∗0.0692.040.100.039C 6-N 20π∗0.153N20-O22π∗0.0692.040.100.039N20-O22π∗0.680C5-C6π∗0.37913.490.110.048[^2][^3][^4]

The NBO analysis predicts the stability of molecules arising from hyperconjugative interactions and charge delocalization. The results clearly show that electron density in anti-bonding orbitals and second order delocalization energies confirm the occurrence of inter-molecular charge transfer within the molecules \[[@bib50]\].

These interactions indicate that the addition of electron withdrawing substituent to aromatic ring results in further molecular stabilization of the compound. Similarly, hyperconjugative interactions within the phenyl ring and between the ring and allyl carbons were seen for other compounds along with other interactions resulting in stabilization of the compounds **1(b-g)**.

3.6. Molecular docking {#sec3.6}
----------------------

The overlapping of docked compounds **1(a-g)** with AM based 3D HDAC8 and HDAC3 binding model is depicted in [Figure 6](#fig6){ref-type="fig"}.Figure 6Binding interaction of the aryl AM designed compounds **1(a-g)** and AM (reference) with I) HDAC8 protein (PDB ID: 1T67) and II) HDAC3 protein (PDB ID: 4A69).Figure 6

The conserved interacting amino acid residues were Tyr 306, His 180, Asp 267, Phe 152, Asp 178, His 142 and His 143. Docking investigations revealed the formation of metal coordinate bond between S and Zn at a distance of 2.348 Å, 2.358 Å and 2.362 Å for compounds **1a**, **1f** and **1g**, respectively. The value for reference AM was 2.56 Å which indicates better binding affinity of compounds **1a**, **1f** and **1g** ([Figure 7](#fig7){ref-type="fig"}).Figure 73D docked models for a) allylmercaptan, b) compound **1a**, c) compound **1f** and d) compound **1g** with HDAC8 in the catalytic core with conserved interacting amino acid residues stabilizing the binding interactions.Figure 7

The glide score, gibbs energy values and Zn-S bond distances for the compounds are listed in [Table 8](#tbl8){ref-type="table"}.Table 8S-Zn bond distance and Glide score values of aryl AM compounds **1(a-g)** and AM with HDAC8 and HDAC3.Table 8CompoundsHDAC8HDAC3Bond length (S- Zn) ÅGlide Score (Kcal/mol)Gibbs free energy (kJ/mol)GlideScore (Kcal/mol)Gibbs free energy (kJ/mol)1a2.348- 4.636-29.05-4.377-15.411b12.09- 4.257-20.44-4.968-19.061c12.35- 3.655-19.39-5.300-12.771d11.91- 4.112-20.36-5.072-18.211e11.40- 3.803-21.14-5.452-18.331f2.358- 4.959-30.08-4.430-12.661g2.362- 4.732-29.56-4.385-17.73AM (Reference)2.56-2.342-25.43-1.959-15.61

The hydrophobic interactions were seen with residues Trp 141, Tyr 306, Met 274, Phe 208 and Phe 152 for all the compounds **1(a-g)** ([Figure 8](#fig8){ref-type="fig"}).Figure 83D docked models for e) compound **1b,** f) compound **1c**, g) compound **1d**, h) compound **1e**, docked in HDAC8 catalytic core with conserved interacting amino acid residues stabilizing the binding interactions.Figure 8

Polar interactions were observed with residues His 180 and His 142. There is preponderance of hydrophobic interactions on the linker chain which indicates that binding majorly takes place in the hydrophobic pocket of the receptor ([Figure 9](#fig9){ref-type="fig"}). It is well known through various published works and our own experiences that both hydrophobic as well as hydrogen binding interactions play pivotal role in complexation of ligands with proteins \[[@bib45], [@bib46], [@bib47]\].Figure 9The dominance of hydrophobic interactions in binding of AM moieties of DADS compounds and HDAC8. The compounds **1a**, **1f** and **1g** also have good glide score values -4.63, -4.95 and -4.73 kJ/mol compared to AM (-2.34 kJ/mol, 2.56 Å).Figure 9

It has been reported that the benzyl mercaptan molecule bulkier than AM inhibited HDAC8 better than Hela nuclear extracts primarily containing HDAC3 indicating specific HDAC8 inhibition \[[@bib29]\]. Watson *et al.* \[[@bib48]\] predicted that the binding site of ligand in HDAC3 is far away from Zn atom a possible reason for selective binding to HDAC8. In the present study the designed aryl AM compounds bearing electron withdrawing groups 1(a-g)were docked with HDAC3 also. [Figure 6](#fig6){ref-type="fig"} (II) depicts docked aryl AM compounds 1(a-g) with HDAC3.

The docking scores and Gibbs energy values were found to be good and comparable to the values as obtained for HDAC8 ([Table 8](#tbl8){ref-type="table"}). The non-covalent interactions like hydrophobic and Vander Waal interactions dominated the binding site. The results clearly state that these new designed aryl AM compounds bearing electron withdrawing substituents show general HDACI action and could be modified accordingly to treat multiple diseases.

4. Conclusion {#sec4}
=============

A comprehensive *in silico* investigation of designed aryl AM compounds **1(a-g)** bearing electron withdrawing substituents was done. The most stable conformation calculated at DFT B3LYP/6-311G++(d,p) level of computation had methyl carbon eclipsed with mercaptansulphur. The structural parameters determined the planarity of the compounds except for sulphur atom which lies slightly above the plane. The electronic properties suggested high chemical reactivity. The NBO results indicated hyperconjugation within the phenyl ring and the ring with allyl carbons. The drug likeliness was confirmed *via*ADME. Docking data suggested the importance of hydrophobic interactions and metal coordination between the ligands **1(a-g)** and receptor. It supports the fact that substitution of aryl AM moiety with electron withdrawing substituents makes aryl AM better general HDACIs. Thus these potential HDACIs candidates could further help in design, development and screening of new pharmacaphores which could be modified for diversified pharmacological actions.
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[^1]: BBB: Blood Brain Barrier, HIA: Human Intestinal Absorption, PPB: Plasma Protein Binding, SP: Skin Permeability.

[^2]: E(2) indicates second order perturbation energy (Stabilization energy in Kcal/mol).

[^3]: Energy difference between donor and acceptor I and j NBO orbitals in a.u.

[^4]: f(I,j) is the Fock matrix elements between I and j NBO orbitals in a.u.
